Physician

Daniel Feldman, MD

According to 2025 Medicare claims, Daniel Feldman, MD (NPI: 1649562307) practices pain management in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is GLENDALE NEUROLOGICAL ASSOCIATES P C (NPI: 1639134414; TIN: 381889896) and primary practice location at 48334-2979.

Feldman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 196 traditional Medicare patients, billed 5,573 HCPCS/CPT codes, and received $173,058 in Medicare payments. The top billing code was 62323 (Injection of substance into lower spine canal using imaging guidance). Part D data shows 282 prescription claims across 57 beneficiaries totaling $14,595 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 13 records totaling $259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,928 and ending at $14,595. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	222	1,360	$53,734
2017	381	4,735	$170,584
2018	226	7,182	$169,106
2019	266	8,390	$189,863
2020	190	7,397	$134,786
2021	152	8,209	$136,909
2022	182	10,415	$156,016
2023	188	10,197	$152,441
2024	196	5,573	$173,058

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	144	$9,928
2016	123	271	$18,259
2017	131	401	$8,954
2018	111	424	$23,568
2019	119	442	$21,586
2020	102	440	$14,913
2021	89	524	$59,645
2022	129	681	$36,261
2023	116	534	$48,869
2024	57	282	$14,595

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
62323	Injection of substance into lower spine canal using imaging guidance	52	82	$197
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	87	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	119	352	$67
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	38	344	$49
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	38	361	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	41	2,310	$803
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	1,870	$570
Nortriptyline Hcl	Nortriptyline Hcl	17	750	$243
Topiramate	Topiramate	19	750	$236
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	390	$204

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$259	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Feldman, MD?

Tedicare shows public-source Medicare data for Daniel Feldman, MD (NPI 1649562307), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Feldman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Feldman, MD?

Daniel Feldman, MD is linked to GLENDALE NEUROLOGICAL ASSOCIATES P C (billing NPI 1639134414) in the available physician profile data.

Does Daniel Feldman, MD have Open Payments data?

Daniel Feldman, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.